Leukocare Overview
- Year Founded
-
2003
- Status
-
Private
- Employees
-
85
- Latest Deal Type
-
PE Growth
- Financing Rounds
-
7
Leukocare General Information
Description
Provider of drug product development services intended to improve developability, manufacturability, and long-term product stability. The company offers formulation development, analytical characterization, and stability studies by utilizing molecular modeling and predictive analytics, providing biopharmaceutical companies with rational formulation strategies for complex biologics.
Contact Information
Website
www.leukocare.comCorporate Office
- Am Klopferspitz 19a
- 82152 Munich
- Germany
Corporate Office
- Am Klopferspitz 19a
- 82152 Munich
- Germany
Leukocare Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Leukocare Comparisons
Industry
Financing
Details
Leukocare Competitors (3)
One of Leukocare’s 3 competitors is Pensatech Pharma, a Corporation company based in Berlin, Germany.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Pensatech Pharma | Corporation | Berlin, Germany | ||||
| Vetter Pharma | Private Debt Financed | Ravensburg, Germany | ||||
| Coriolis Pharma | Venture Capital-Backed | Martinsried, Germany |
Leukocare Patents
Leukocare Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20250277056-A1 | Novel method of producing a liquid biopharmaceutical drug product | Pending | 29-Feb-2024 | ||
| WO-2025125222-A1 | Compositions comprising viruses, viral vectors or virus-like particles | Inactive | 11-Dec-2023 | ||
| AU-2022426762-A1 | Fibrinogen and thrombin solutions for a fibrin sealant and fibrin sealant kit | Pending | 30-Dec-2021 | ||
| EP-4456935-A1 | Fibrinogen and thrombin solutions for a fibrin sealant and fibrin sealant kit | Pending | 30-Dec-2021 | ||
| US-12472237-B2 | Fibrinogen and thrombin solutions for a fibrin sealant and fibrin sealant kit | Active | 30-Dec-2021 | A61K38/363 |
Leukocare Signals
Leukocare Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Leukocare FAQs
-
When was Leukocare founded?
Leukocare was founded in 2003.
-
Where is Leukocare headquartered?
Leukocare is headquartered in Munich, Germany.
-
What is the size of Leukocare?
Leukocare has 85 total employees.
-
What industry is Leukocare in?
Leukocare’s primary industry is Other Pharmaceuticals and Biotechnology.
-
Is Leukocare a private or public company?
Leukocare is a Private company.
-
What is Leukocare’s current revenue?
The current revenue for Leukocare is .
-
How much funding has Leukocare raised over time?
Leukocare has raised $24M.
-
Who are Leukocare’s investors?
Petrichor Healthcare Capital Management, Rentschler Biopharma, and KfW Group have invested in Leukocare.
-
Who are Leukocare’s competitors?
Pensatech Pharma, Vetter Pharma, and Coriolis Pharma are competitors of Leukocare.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process